BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW)

CUSIP: G11217125

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / *W EXP 12/02/202
Total 13F shares
4,387,939
Share change
+317,942
Total reported value
$205,515
Price per share
$0.05
Number of holders
18
Value change
-$14,944
Number of buys
3
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G11217125?
CUSIP G11217125 identifies BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) as of Q4 2022

As of 31 Dec 2022, BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,387,939 shares. The largest 10 holders included Periscope Capital Inc., Saba Capital Management, L.P., Polar Asset Management Partners Inc., Linden Advisors LP, Calamos Advisors LLC, KIM, LLC, Sculptor Capital LP, EHP Funds Inc., Context Capital Management, LLC, and WOLVERINE ASSET MANAGEMENT LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.